EXO Biologics

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2000000.0,
      "currency": "EUR",
      "after_eur": 7181820.14,
      "delta_eur": 2000000.0,
      "before_eur": 5181820.14,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-12-31",
      "evidence_quote": "augmenter le capital \u00E0 concurrence de deux millions (\u20AC 2.000.000,00) pour le porter de cinq millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 5.181.820,14) \u00E0 sept millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 7.181.820,14) par la cr\u00E9ation quatre mille six cent neuf (4.609) nouvelles Actions Classe A ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es ... en r\u00E9mun\u00E9ration de l\u2019apport, \u00E0 concurrence de deux millions (\u20AC 2.000.000,00), d\u2019une cr\u00E9ance qu\u2019il d\u00E9tient sur la soci\u00E9t\u00E9.",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_decrease",
      "amount": 2061102.26,
      "currency": "EUR",
      "after_eur": 5120717.88,
      "delta_eur": -2061102.26,
      "before_eur": 7181820.14,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-12-31",
      "evidence_quote": "r\u00E9duire le capital \u00E0 concurrence de deux millions soixante et un mille cent deux euros vingt-six cents (\u20AC 2.061.102,26) pour le ramener de sept millions cent quatre-vingt-un mille huit cent vingt euros quatorze cents (\u20AC 7.181.820,14) \u00E0 cinq millions cent vingt mille sept cent dix-sept euros quatre-vingt-huit cents (\u20AC 5.120.717,88) par apurement de la totalit\u00E9 des pertes subies au 31 d\u00E9cembre 2024 et sans r\u00E9duction du nombre d\u2019actions.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "notary": {
    "name": "Frederik Vlaminck",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-12-20",
    "filing_date": "2024-12-18",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2024-12-12",
    "unanimous": null
  },
  "agm_change": {
    "new_schedule": null,
    "old_schedule": null,
    "effective_from_year": null,
    "rule_changes_summary": "Adaptation of article 5 of the statutes to the new capital situation, replacing the first sentence with a new clause defining the capital."
  },
  "detected_kind": "agm_rules_change",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO Biologics",
    "legal_form": "SA"
  },
  "accounts_deposit": {
    "filing_kind": null,
    "fiscal_year_end": "2023-12-31",
    "filing_reference": "*24453545*"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal du 12 d\u00E9cembre 2024",
    "procurations",
    "texte des statuts",
    "extrait"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 691666.0,
      "currency": "EUR",
      "after_eur": 10314687.9,
      "delta_eur": 691666.0,
      "before_eur": 9623021.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-03",
      "evidence_quote": "augmenter le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de six cent nonante-et-un mille six cent soixante-six euros (\u20AC 691.666,00) pour le porter de neuf millions six cent vingt-trois mille vingt et un euros nonante cents (\u20AC 9.623.021,90) \u00E0 dix millions trois cent quatorze mille six cent quatre-vingt-sept euros nonante cents (\u20AC 10.314.687,90) par apport en num\u00E9raire",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Amel TOUNSI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "Par un courrier du 6 f\u00E9vrier 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. EXO BIOLOGICS, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Eric BRANDT, avec effet au 7 f\u00E9vrier 2024"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric BRANDT",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "Par un courrier du 6 f\u00E9vrier 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. EXO BIOLOGICS, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Eric BRANDT, avec effet au 7 f\u00E9vrier 2024"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Amel TOUNSI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0732982379",
        "name": "NOSHAQ IMMO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Yvan ABSIL, avec effet au 7 f\u00E9vrier 2024"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yvan ABSIL",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0732982379",
        "name": "NOSHAQ IMMO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-02-07",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Yvan ABSIL, avec effet au 7 f\u00E9vrier 2024"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2627152.0,
      "currency": "EUR",
      "after_eur": 7248021.9,
      "delta_eur": 2627152.0,
      "before_eur": 4620869.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-12-29",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de deux millions six cent vingt-sept mille cent cinquante-deux euros (\u20AC 2.627.152,00) pour le porter de quatre millions six cent vingt mille huit cent soixante-neuf euros nonante cents (\u20AC 4.620.869,90) \u00E0 sept millions deux cent quarante-huit mille vingt et un euros nonante cents (\u20AC 7.248.021,90) par la cr\u00E9ation de six mille cent septante-et-un (6.171) nouvelles Actions Classe C... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019\u00E9gard de la soci\u00E9t\u00E9 \u00E0 concurrence de deux millions six cent vingt-sept mille cent cinquante-deux euros (\u20AC 2.627.152,00) au total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 2375000.0,
      "currency": "EUR",
      "after_eur": 9623021.9,
      "delta_eur": 2375000.0,
      "before_eur": 7248021.9,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-12-29",
      "evidence_quote": "d\u2019augmenter le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de deux millions trois cent septante-cinq mille euros (\u20AC 2.375.000,00) pour le porter de sept millions deux cent quarante-huit mille vingt et un euros nonante cents (\u20AC 7.248.021,90) \u00E0 neuf millions six cent vingt-trois mille vingt et un euros nonante cents (\u20AC 9.623.021,90) par apport en num\u00E9raire et par la cr\u00E9ation de cinq mille cinq cents (5.500) actions... qui seront imm\u00E9diatement lib\u00E9r\u00E9es enti\u00E8rement",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 5000000,
      "currency": "EUR",
      "after_eur": 5600000,
      "delta_eur": 5000000,
      "before_eur": 600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de cinq millions (\u20AC 5.000.000,00) pour le porter de six cent mille (\u20AC 600.000,00) \u00E0 cinq millions six cent mille euros (\u20AC 5.600.000,00) par la cr\u00E9ation de seize mille deux cent quatorze (16.214) nouvelles actions ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019encontre de la soci\u00E9t\u00E9 \u00E0 concurrence de cinq millions (\u20AC 5.000.000,00) en total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 3000000,
      "currency": "EUR",
      "after_eur": 8600000,
      "delta_eur": 3000000,
      "before_eur": 5600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "d\u2019augmenter le capital \u00E0 concurrence de trois millions (\u20AC 3.000.000,00) pour le porter de cinq millions six cent mille euros (\u20AC 5.600.000,00) \u00E0 huit millions six cent mille euros (\u20AC 8.600.000,00) par la cr\u00E9ation de huit mille quatre cent soixante-sept (8.467) nouvelles actions ... destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es, en tant qu\u2019actions enti\u00E8rement lib\u00E9r\u00E9es, en r\u00E9mun\u00E9ration de l\u2019apport des cr\u00E9ances d\u00E9tenues par les souscripteurs \u00E0 l\u2019encontre de la soci\u00E9t\u00E9 \u00E0 concurrence de trois millions (\u20AC 3.000.000,00) en total",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_decrease",
      "amount": 3979130.1,
      "currency": "EUR",
      "after_eur": 4620869.9,
      "delta_eur": -3979130.1,
      "before_eur": 8600000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-09-11",
      "evidence_quote": "de r\u00E9duire le capital \u00E0 concurrence de trois millions neuf cent septante-neuf mille cent trente euros dix cents (\u20AC 3.979.130,10) pour le ramener de huit millions six cent mille euros (\u20AC 8.600.000,00) \u00E0 quatre millions six cent vingt mille huit cent soixante-neuf euros nonante cents (\u20AC 4.620.869,90) par apurement de la totalit\u00E9 des pertes subies au 31 d\u00E9cembre 2022",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Hugues Wallemacq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0741644479",
        "name": "Biotech Management \u0026 Consulting SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Apr\u00E8s d\u00E9lib\u00E9ration, le Conseil d\u00E9cide \u00E0 l\u0027unanimit\u00E9 (i) de nommer la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u003C Biotech Management \u0026 Consulting \u003E, avec adresse \u00E0 4458 Fexhe-Slins, Rue Neuve 31, num\u00E9ro d\u0027entreprise 0741.644.479 (RPM Li\u00E8ge, division Li\u00E8ge), comme d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, qui sera rep"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "JURGA Marcin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nominer les personnes suivantes comme administrateur de la Soci\u00E9t\u00E9 jusque la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2026: -Monsieur JURGA Marcin, habitant \u00E0 2840 Rumst, Kloosterstraat 28;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "TOUNSI Amel",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0426624509",
        "name": "NOSHAQ",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "la soci\u00E9t\u00E9 anonyme NOSHAQ, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, Rue Lambert-Lombard 3, num\u00E9ro d\u0027entreprise 0426.624.509 (RPM Li\u00E8ge, division Li\u00E8ge), qui a d\u00E9clar\u00E9 de nommer en qualit\u00E9 de repr\u00E9sentant permanent, Madame TOUNSI Amel, habitant \u00E0 1090 Jette, Jean Gabinplein 1 A1;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DALTON Colin Clive",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Margarite Limited",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "la soci\u00E9t\u00E9 \u00E9trang\u00E8re Margarite Limited, ayant son si\u00E8ge \u00E0 Quorn, Leicestershire, LE12 8DX (Royaume-Uni), 78 Loughborough Road, qui sera repr\u00E9sent\u00E9e de fa\u00E7on permanente par Monsieur DALTON Colin Clive, habitant \u00E0 Ketteringham, WYMONDHAM, Norfolk, NR18 9RU (Royaume-Uni), The Lodge, High Street."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO BIOLOGICS",
    "legal_form": "SA"
  }
}

{
  "kind": "oprichting",
  "seat": "Boulevard Gustave-Kleyer 17, 4000 Li\u00E8ge",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "VAN ROMPAY Pieter",
        "niss": null,
        "address": "Lindenlaan 3, 2580 Putte"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "VAN ROMPAY Pieter",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "VAN ROMPAY Stijn",
        "niss": null,
        "address": "Vlieghavenlaan 24, 3140 Keerbergen"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "VAN ROMPAY Stijn",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "FOIDART Jean Michel Francine Charles Simonne Ren\u00E9",
        "niss": null,
        "address": "4870 Trooz, Rue Sur la Heid 3"
      },
      "share_class": "nominative",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 200000,
      "holder_person_name": "FOIDART Jean Michel Francine Charles Simonne Ren\u00E9",
      "is_subscriber_only": false,
      "n_shares_subscribed": 20000,
      "amount_subscribed_eur": 200000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 600000,
  "subject_company": {
    "kbo": "0732.982.379",
    "name_full": "EXO Biologics",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2019-08-28",
  "post_incorporation_mandates": []
}